Tag: ICH Q9 application

Applying ICH Q9 for Deviation Risk Assessment in Pharma Stability Studies

💡 Introduction: Why Risk-Based Deviation Handling Matters In the pharmaceutical industry, not all deviations pose the same threat to product quality, patient safety, or data integrity. A minor oversight during documentation and a temperature excursion in a stability chamber cannot be treated with equal urgency. This is where the principles of ICH Q9 — Quality…

Handling Deviations and CAPA in Stability Reports, Protocols and Reports

How to Justify Reduced Testing Schedules Using Risk Assessments

Pharmaceutical companies increasingly seek to streamline stability programs without compromising product quality or regulatory compliance. Justifying reduced testing schedules using risk assessments has become a key component of Quality Risk Management (QRM), enabling optimized protocols aligned with ICH Q9 and Q1E. This article provides a how-to guide for designing reduced testing schedules with robust scientific…

Pharmaceutical Quality and Practices, Risk-Based Approaches to Stability Testing

Training Stability Teams on Risk-Based Testing Methodologies

Risk-based approaches in pharmaceutical stability testing have evolved from regulatory guidance into a best-practice expectation. While Quality Risk Management (QRM) principles outlined in ICH Q9 offer a framework, successful implementation depends heavily on training the people executing stability studies. This tutorial explains how to design and deliver impactful training for stability teams adopting risk-based methodologies….

Pharmaceutical Quality and Practices, Risk-Based Approaches to Stability Testing

Case Study: Risk-Based Reduction of Storage Time Points

Stability studies are resource-intensive and time-consuming, especially when following traditional, rigid time point schedules. However, applying risk-based approaches guided by ICH Q9 and ICH Q1A allows sponsors to scientifically reduce the number of storage time points without compromising data integrity or regulatory expectations. In this case-based article, we explore how one pharmaceutical company successfully implemented…

Pharmaceutical Quality and Practices, Risk-Based Approaches to Stability Testing

ICH Q9 Integration in Stability Planning

Stability studies are a critical component of pharmaceutical product lifecycle management. With global regulatory bodies emphasizing a risk-based approach, integrating ICH Q9 Quality Risk Management (QRM) principles into stability planning has become essential for compliance, cost-efficiency, and scientific justification. This tutorial outlines a systematic way to implement ICH Q9 in designing, executing, and documenting stability…

Pharmaceutical Quality and Practices, Risk-Based Approaches to Stability Testing

How to Apply Risk Management Principles to Stability Testing

Pharmaceutical companies are increasingly embracing risk-based approaches to optimize stability testing. Applying the principles of ICH Q9: Quality Risk Management enables targeted study designs, efficient resource use, and robust regulatory compliance. In this guide, we explain how to integrate risk thinking into every stage of stability planning—from protocol creation to shelf-life assignment. 🎯 Why a…

Pharmaceutical Quality and Practices, Risk-Based Approaches to Stability Testing